Use of Ambroxol as Therapy for Gaucher Disease

IMPORTANCE: Ambroxol was identified as an enhancer of stability and residual activity of several misfolded glucocerebrosidase variants in 2009. OBJECTIVES: To assess hematologic and visceral outcomes, biomarker changes, and safety of ambroxol therapy for patients with Gaucher disease (GD) without di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Xia, Zhang, Huiwen, Maegawa, Gustavo H. B., Wang, Yu, Gao, Xiaolan, Wang, Dengbin, Li, Jinning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285580/
https://www.ncbi.nlm.nih.gov/pubmed/37342037
http://dx.doi.org/10.1001/jamanetworkopen.2023.19364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285580/
https://www.ncbi.nlm.nih.gov/pubmed/37342037
http://dx.doi.org/10.1001/jamanetworkopen.2023.19364

Ejemplares similares